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Hydroxytyrosol (HT) is involved in healthful activities and is beneficial to lipid metabolism. Many investi-
gations focused on finding tissue-specific targets of HT through the use of different omics approaches
such as transcriptomics and proteomics. However, it is not clear which (if any) of the potential molecular
targets of HT reported in different studies are concurrently affected in various tissues. Following the bioin-
formatic analyses of publicly available data from a selection of in vivo studies involving HT-supplemen-
tation, we selected differentially expressed lipid metabolism-related genes and proteins common to more
than one study, for validation in rodent liver samples from the entire selection. Four miRNAs (miR-802-
5p, miR-423-3p, miR-30a-5p, and miR-146b-5p) responded to HT supplementation. Of note, miR-802-
5p was commonly regulated in the liver and intestine. Our premise was that, in an organ crucial for lipid
metabolism such as the liver, consistent modulation should be found for a specific target of HT even if
different doses and duration of HT supplementation were used in vivo. Even though our results show
inconsistency regarding differentially expressed lipid metabolism-related genes and proteins across
studies, we found Fgf21 and Rora as potential novel targets of HT. Omics approaches should be fine-
tuned to better exploit the available databases.
1. Introduction
3,4-Dihydroxyphenylethanol (hydroxytyrosol, HT), the main
olive oil phenolic compound, is mostly found as part of
complex (poly)phenols (secoiridoids),1 which are easily hydro-
lyzed to yield HT after ingestion.2 As digestion progresses, HT-
derived metabolites (mainly its sulfate form) become the main
compounds circulating in blood3,4 and are recovered in urine.5
The biological properties of HT have been widely investigated
in different research areas including nutrition, medicine,
pharmacology, chemistry and biotechnology.6 This phenol is
now considered as one of the most bioactive natural mole-
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cules.7 In vitro, HT is an antioxidant8 and its intake may bene-
ficially influence cardiovascular disease (CVD) risk, via its
potential to induce anti-atherosclerotic,9 hypotensive, anti-
oxidant, anti-inflammatory,10 and hypocholesterolemic
effects.11 Of note, the European Food Safety Authority (EFSA)
issued a health claim based on consistent results regarding
the protective effects of olive polyphenols against the oxidation
of blood lipids.11
Investigations that use cutting-edge, high-throughput, tech-
niques referred to as “omics” are increasingly popular.12
Omics tools have allowed the deepening of the knowledge on
metabolism changes and identifying new potential disease
(such as CVD) biomarkers, in a way that was not possible by
genetic techniques alone.13 In this sense, dietary intervention
studies have successfully used transcriptomics and proteomics
to show the mode through which diet induces alterations in
gene and protein expression, providing information about the
mechanisms of action and pathways regulated by micronutri-
ents and helping in the identification of new biomarkers.14
However, in contrast to other fields of study,15 very few initiat-
ives focusing on the establishment of databases that integrate
largescale nutritional and genomics or genetics data have
been developed.15–17 The majority of such actions are aimed at
standardizing nutritional studies and some publications –
sometimes – over-emphasize the results obtained via database
interrogation. Indeed, the scientific literature only describes
two examples of such large-scale nutritional genomic data ana-
lysis: one related to functional genomics in chicken
(Dhanasekaran et al., 2014)18 and the other one to genomic
responses triggered by food bioactive compounds.12 Indeed, it
is complicated to extract the most relevant information from
the large amount of data being produced worldwide, although
such an approach would greatly strengthen scientific
conclusions.19
By integrating transcriptomic and proteomic data, our
initial goal was to identify consistently modulated potential
molecular targets of HT reported in different studies where
this compound was supplemented in vivo. We then used liver
samples, a key tissue in lipid metabolism, obtained from
different HT rodent studies to evaluate whether the previously
identified candidates could be considered as solid targets
of HT.
2. Materials and methods
2.1 Data collection and gene selection
From the PubMed and Scopus scientific databases, we gath-
ered studies on in vivo supplementation with HT or its pheno-
lic precursors, where gene and protein differential expressions
were screened. Specific queries were launched with keywords
such as “hydroxytyrosol AND proteomic”, “hydroxytyrosol AND
transcriptomic”, “hydroxytyrosol AND gene”, “hydroxytyrosol
AND protein”, “hydroxytyrosol AND miRNA”, “hydroxytyrosol
AND mRNA”, “hydroxytyrosol AND genomic”. We generated
Venn diagrams of data from the selected studies, by means of
in-house R scripts, to find intersections among differentially
expressed genes.
Functional enrichment. Genecodis3 software was used for
functional enrichment using default parameters and selecting
GO biological processes as target annotations.
Statistical analysis. Moderated t-test statistics were applied
to microarray features once a linear model was fitted.
Statistical significance of the overrepresented GO biological
processes in the target gene list was assessed through the chi-
square test. The false discovery rate (FDR) method was
employed to adjust the obtained p-values.
2.2 Ethics statements
All animal studies were approved by the respective Animal
Ethics Committee of the institutions where each animal exper-
imentation took place, namely: University Complutense of
Madrid (CEA-UCM 93/2012; CEEA 10-06/14, 31st July 2014),
University of Lleida, and Universidad Mixta de Investigación,
Zaragoza. All procedures followed the Guide for the Care and
Use of Laboratory Animals, published by the US National
Research Council (Eighth Edition, 2010), except for the study
by Acin et al. (Study 3, see below), which is prior to 2010 and
followed the Ethical Committee for Animal research of the
University of Zaragoza.
2.3 Brain and liver microarray analysis
Gene expression profiles in brain and liver tissues were ana-
lyzed using the Illumina MouseRef-8 v2 Expression
BeadChip® platform with Ambion Labelling. Four biological
replicates per group were included. This BeadChip targets
approximately 25 600 well-annotated RefSeq transcripts, repre-
senting over 19 100 unique genes. Data were background-cor-
rected and normalized using GenomeStudioTM Software
(Illumina, San Diego, CA, USA) and following the manufac-
turer’s instruction. Differential expression was assessed using
the Limma’s Bioconductor package in the R statistical pro-
gramming environment.
2.4 Liver samples used for transcriptomic and proteomic
validations
Transcriptomic and proteomic validations were performed in
liver samples obtained from a selection of four previously pub-
lished studies where HT was administered to rodents, as
follows: (1) study from Tomé-Carneiro et al. (2016), hereon
referred to as Study 1. Briefly, in this study young C57BL/
6 mice (2 months old, n = 14) were fed a purified control
diet alone (n = 7) or supplemented with approximately 45 mg
HT per kg bw per day (Seprox Biotech, Madrid, Spain) (n = 7),
for 8 weeks.20 (2) A second cohort from the Tomé-Carneiro
et al. (2016)20 study, hereon referred to as Study 2. Briefly, in
this acute ingestion study, 15 mg of HT dissolved in water
(Seprox Biotech, Madrid, Spain) were administered (by gavage)
to young C57BL/6 mice (10 weeks old), which were sacrificed
immediately (control group, n = 9) or 4 h after ingestion (n =
9). (3) Study from Acín et al. (2006), hereon referred to as Study
3. Briefly, for 10 weeks, 14 homozygous apoE KO mice
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(2 months old, n = 14) were given free access to drinking water
(control group, n = 7) or to an aqueous solution and provided a
dose of 10 mg HT per kg per day (n = 7).21 (4) Study from
Catalán et al. (2016), hereon referred to as Study 4. Briefly,
female Wistar rats (300–350 g, n = 8) were fed a standard diet
(SD) (control group, n = 4) or SD supplemented with 5 mg of
secoiridoids per kg per day (n = 4), for 21 days.22
2.5 Transcriptomic validations
Commonly differentially expressed genes identified in the
Venn diagram (Fig. 1) were used for transcriptomic validations.
Oligonucleotide primers were designed to amplify the selected
genes in both mouse and rat species. Gene function and
primers are listed in Table 1. Briefly, total RNA was isolated
from liver samples using a Trizol/Qiagen RNeasy kit. cDNA
synthesis was performed with 1 µg of RNA using the miScript
II RT kit (Qiagen) according to the supplier’s instructions.
qPCR was carried out in a ABI 7900 HT Real-time PCR system
with a 384 well plate format, using the FastStart Essential DNA
Green Master mix (Roche, Switzerland) at 95 °C for 10 min, fol-
lowed by 40 cycles at 95 °C for 15 s and 58 °C for 1 min. Gene
expression was normalized with respect to Gapdh expression,
and relative quantification was calculated using the 2ΔΔCt
method.
2.6 Proteomic validations
For proteomic validations, protein selection was based on the
commonly differentially expressed proteins identified in the
corresponding Venn diagram (Fig. 3). Antibodies used and
functions of the selected proteins are described in Table 2.
Briefly, the liver samples from the four above-mentioned
studies were homogenized in RIPA buffer (200 mM sodium
orthovanadate, 1 mM Pefabloc SC, and 2 mg mL−1 protease
inhibitor cocktail (Sigma, Madrid, Spain)), sonicated for 5 min
and frozen overnight at −80 °C. After centrifugation at 12 000g
for 30 min at 4 °C, the supernatant was collected for total
protein quantification using a Pierce BCA Protein Assay kit
(Thermo Fisher Scientific) according to the manufacturer’s
protocol. For western blotting, 30 µg of total protein were elec-
trophoresed in 6–15% SDS-PAGE gel and then transferred onto
nitrocellulose membranes. The membranes were blocked with
LiCor blocking buffer at RT for 1 h. Overnight incubation at
4 °C was performed with a primary antibody followed by incu-
bation (1 h, RT) with the LiCor fluorescent secondary antibody
(goat anti-Mouse IRDye® 800 CW or goat anti-Rabbit IRDye®
680 CW). The membranes were visualized using a LiCor
Odyssey scanner. Proteins were quantified by densitometry
using Image Studio Lite 5.2.5 analytical software (LiCor,
Lincoln, NE) and normalized to GAPDH.
2.7 miRNA analysis
For miRNA analysis, an unbiased whole genome miRNA ana-
lysis was performed in the mice liver samples (n = 5 per group)
from Study 1 using small RNA sequencing. RNA integrity was
determined using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA). Following the manufacturer’s
protocol, a NEBNext® multiplex small RNA Library Prep Set for
Illumina (New England BioLabs, Ipswich, MA) was used to
prepare the libraries, and sequenced using the Illumina
NextSeq 500 platform. After trimming adapter sequences,
Bowtie2 was used for read alignment against high confidence
mouse mature miRNA sequences, obtained from the miRBase
Fig. 1 Venn diagram showing the common differentially expressed genes identified through bioinformatic analysis. Transcriptomic data available in
public repositories from in vivo dietary supplementation with hydroxytyrosol. Gene differential expression was analyzed using LIMMA models.
Food & Function Paper























































database. Finally, only reads showing a unique valid alignment
against the reference sequences were considered for mature
miRNA counting.
2.8. miRNA bioinformatic analysis
MicroRNAs’ targets presenting hits on the 3′UTR position and
showing a binding P-value score equal to 1 were obtained from
the miRWalk 3.0 database23 and used for further analysis. A
functional enrichment of these genes, targeted by at least two
of the differentially expressed microRNAs, was performed in
the Panther database v.1124 using Gene Ontology (GO) and
Panther pathway annotations. A subset of four significantly
modulated miRNAs in response to HT supplementation were
used for Gene Interaction (GI) analysis using the above-men-
tioned target genes. GI analysis was performed as previously
described20 including target genes targeted at least by two
miRNAs. The target dot size was directly correlated with the
number of interactions with the set of miRNAs. As for the
functional analysis, only the genes targeted simultaneously by
at least two miRNAs are shown.
2.9. Statistical analysis
Comparisons between HT-supplemented groups and controls
were performed by means of two-tailed t tests or Mann–
Whitney tests; when assumptions for parametric testing were
not met GraphPad Prism 7.02 (La Jolla, CA) was used. In all
cases, p < 0.05 was considered as statistically significant.
3 Results
3.1 Identification of common differentially expressed genes
Specific searches in public scientific databases for in vivo inter-
ventions involving hydroxytyrosol supplementation returned
scarce results (Table 3). The GEO database, which contains
high throughput genomic and proteomic data among others,




B-Efr3a CTTTGCGTCCTCGCTACAAAC CCATATCAGCTTTAACAAGGCCA Involved in the functional maintenance of sensory and motor
nervous tissues.
B-Kctd2 CCTACTTCGTGACCACCAGAC GAGTTTTCCATGGCGGAGGT Potassium channel tetramerization domain containing protein
2.








CAGAAGTCCGAGGGTTGTGTA CAGATGGTTTCCAAAGACTGCTT Involved in the regulation of cell division, glycogen
metabolism, and muscle contractility.
B-Tjp2 GTTTGCCGTTCAGCAGCTTAG CTTCAAAACCTCGGTCGTCAT Component of the tight junction barrier in epithelial and
endothelial cells.
B-Top1 GCCAAGGTGTTCCGTACCTA TCAGGTCCTTTCGAGCATCT Essential for cell growth and division in vivo.
B-Snx16 CCAGAAGAAAGCTGGGTAGTTTT GGAAGTGCTAATCGAAAGCCTG Involved in cholesterol transport, and transport of tetraspanin
CD81.
B-Anks6 GGAGCTGGGGATTAAGACGG TAGAATCTGCCTCTCACGCC Plays a role in renal and cardiovascular development.
B-Plscr2 CTGGGTATGCCCCTCAGTATC GGGAACTTGGTAGTTAGTCTGGA Plays an active role in altering lipid asymmetry at the plasma
membrane.
B-Soat1 GAAGGCTCACTCATTTGTCAGA GTCTCGGTAAATAAGTGTAGGCG Catalyzes the formation of fatty acid-cholesterol esters.
B-Fgf21 CAGATGTGGGTTCCTCCGAC AAGATGCATAGCTGGGGCTT Secreted endocrine factor that functions as a major metabolic
regulator.
R-Crot AAGCCGGGTGCAGGAGTTTT CCACTCTTCCAGCCAGTTTCT Plays a role in lipid metabolism and fatty acid beta-oxidation.
M-Crot GAACGGACATTTCAGTACCAGG CTTCATTTGCGAATGGTTTCACT
B-Rora GTGGAGACAAATCGTCAGGAAT GACATCCGACCAAACTTGACA Controls lipid homeostasis by negatively regulating the
transcriptional activity of PPARγ, that mediates hepatic lipid
metabolism.
B-Sorl1 CCCAGCCTATCCAGGTGTATG CGGGCTAATGCCACGATCA Binds LDL and transports it into cells by endocytosis.
B-Elovl1 GAAGAAGGACGGGCAAGTGA TTGCAGCTGGGCATGAAGTA Involved as the precursors of membrane lipids and lipid
mediators.
B-Acsl4 CTCACCATTATATTGCTGCCTGT TCTCTTTGCCATAGCGTTTTTCT Plays a key role in lipid biosynthesis and fatty acid
degradation.
B-Lipe GTTACCACCCTGCAGTCCTC AAGTGTCTCTCTGCACCAGC Converts cholesteryl esters to free cholesterol for steroid
hormone production.
B-Lpin2 GAAGTGGCGGCTCTCTATTTC AGAGGGTTACATCAGGCAAGT Plays a role in triglyceride metabolism.
Efr3a: EFR3 homolog A; Kctd2: potassium channel tetramerization domain containing 2; Plscr1: phospholipid scramblase 1; Slc37a4: solute
carrier family 37 member 4; Ppp1cb: protein phosphatase 1 catalytic subunit beta; Tjp2: tight junction protein 2; Top1: DNA topoisomerase I;
Snx16: sorting nexin 16; Anks6: ankyrin repeat and sterile alpha motif domain containing 6; Plscr2: phospholipid scramblase 2; Soat1: sterol
O-acyltransferase 1; Fgf21: fibroblast growth factor 21; Crot: carnitine O-octanoyltransferase; Rora: RAR-related orphan receptor alpha; Sorl1:
sortilin related receptor 1; Elovl1: ELOVL fatty acid elongase 1; Acsl4: acyl-CoA synthetase long chain family member 4; Lipe: hormone sensitive
type lipase E; Lpin2: lipin 2; B: Primer designed for both species, Mus musculus and Rattus norvegicus; R: Rattus norvegicus; M: Mus musculus.
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only accounted for two studies concerning gene expression in
humans (GSE75027 and GSE75026) after olive oil intake
(where HT is preeminent). Moreover, only one study concern-
ing an in vivo intervention with HT was found, where a breast
tumor-induced model of Rattus norvegicus was used
(GSE15944).25 Finally, two sets of data from a study carried out
in our laboratory (ESI Tables S1 and S2;† not available in scien-
tific databases), regarding microarray screening in brain and
liver tissues from diet-HT supplemented mice,26 were included
in this study. The aforementioned five sets of data were used
to find mutual differentially expressed genes (Fig. 1). Efr3,
Kctd2, Plscr1 and Scl37a4 were identified as differentially
expressed after HT supplementation in all analyzed data sets.
3.2 Transcriptomic validations
After the identification of differentially expressed genes shared
by at least three studies (Fig. 1 and ESI Table S3†), 18 genes
associated with lipid metabolism were finally selected for vali-
dation. Validation was performed in the liver samples from HT-
supplemented animal models vs. controls (Fig. 2) taken from the
four selected studies (Studies 1–4, see Materials and methods for
details). In the liver samples from Study 1 a statistically signifi-
cant increase was seen in Tjp2, Top1, Rora, Sorl1, Fgf21 and
Ppp1cb (Fig. 2A). In the liver samples from Study 2 a statistically
significant increase was seen in Slc37a4, Snx16, Rora and Fgf21,
whereas a statistically significant decrease was observed in Sorl1
(Fig. 2B). In the liver samples from Study 3 a statistically signifi-
cant increase was seen in Slc37a4, Anks6, Plscr2 and Lipe
(Fig. 2C). In the liver samples from Study 4 a statistically signifi-
cant increase was seen in Sorl1 (Fig. 2D).
3.3 Identification of common differentially expressed proteins
Publicly available large-scale proteomics data regarding HT
supplementation are scarce. To determine whether HT con-
sumption affects specific signaling pathways, we comprehen-
sively analyzed publications involving in vivo HT supplemen-
tation to extract protein expression information from the
reported data tables (Table 4). Then, the collected proteomic
data were subjected bioinformatic analyses to identify differen-
tially expressed proteins common to at least two of these
studies (Fig. 3). Bioinformatic analysis showed that ALDH2,
SELENBP1, HSPD1, PPIA, VIM, YWHAG, RPL8, ACTN4, NPM1,
Table 2 Selected proteins and types of antibodies used
Proteins Company
Molecular
weight (kDa) Host Function
CAR3 Thermo Fisher 29.6 Rabbit Involved in oxidative stress.
FASN Cell Signaling 273 Rabbit Main function is to catalyze the synthesis of palmitate from
acetyl-CoA and malonyl-CoA.
PRDX1 Cell Signaling 21 Rabbit Belongs to a family of antioxidant enzymes. Reduction of hydrogen
peroxide and alkyl hydroperoxides.
VIM Cell Signaling 57 Rabbit Involved in neurogenesis and cholesterol transport.
GAPDH Sigma 37 Mouse Housekeeping protein.
HSPD1 Bethyl 60 Rabbit Involved in stress response.
ACTN4 Bethyl 110 Rabbit Transcriptional coactivator, stimulating transcription mediated
by the nuclear hormone receptors PPARG and RARA.
CAR3: Carbonic anhydrase 3; FASN: fatty acid synthase; PRDX1: peroxiredoxin 1; VIM: vimentin; HSPD1: heat shock protein family D (Hsp60)
member 1; ACTN4: actinin alpha 4; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.
Table 3 In vivo studies involving supplementation with hydroxytyrosol where transcriptomic analyses were performed
Model Dose & time Analysis Aim of study Reference
Male C57BL/6J
mice
5 mg per kg bw HT. qRT-PCR Evaluate the molecular adaptations in the liver involved in the




20 mg HT per kg bw per
day 21 days.
qRT-PCR Identify early, predictive biomarkers for WAT expansion. 70
Male db/db mice 10 or 50 mg HT per kg
per day. 8 weeks





10 or 50 mg HT per kg
per day. During gestation
qRT-PCR Investigate the HT effect on the prenatal stress 72
Male C57BL/
6 mice




Nutrigenomic effects of HT with specific reference to the adipose




0.5 mg kg−1 6 week Microarray
qRT-PCR
Hydroxytyrosol inhibits growth and cell proliferation and




0.03 g% HT 8 weeks Microarray
qRT-PCR
Chronic hydroxytyrosol feeding modulates glutathione-mediated




0.03 g% HT 8 weeks Microarray
qRT-PCR
Hydroxytyrosol supplementation modulates the expression of
miRNAs in rodents and in humans.
20
HT: Hydroxytyrosol.
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ALB, HSP90AB1, CAR3, FASN, HBB-B1, PRDX1, CFL1, GLUD1,
VCL, DLAT, and GPD1 proteins were common to at least 2
studies. Only two proteins, Hspd1 and Actn4, were common to
three studies.
3.4 Proteomic validations
After the identification of differentially expressed proteins,
common to at least two studies, validation was carried out in
Fig. 2 Validation of common transcripts predicted to be modulated by hydroxytyrosol supplementation. A set of transcripts were chosen from
bioinformatic analysis and validated in the liver samples of different intervention studies. Gene expression was analyzed by RT-qPCR. (A) Male young
C57BL/6 mice (n = 7 per group) fed with a control or HT diet (45 mg HT per kg bw per day), for 8 weeks (Study 1). (B) Male young C57BL/6 mice
were administered (gavage) an acute dose of 15 mg of HT (dissolved in water) and sacrificed 4 h after ingestion (n = 9) (Study 2). (C) Male young
homozygous apoE KO mice (n = 7 per group) fed with an aqueous solution of 10 mg HT per kg per day (n = 7), for 10 weeks (Study 3). (D) Female
Wistar rats (300–350 g, n = 4 per group) fed with a standard diet (SD) or SD supplemented with 5 mg HT per kg per day, for 21 days (Study 4). HT,
hydroxytyrosol.
Table 4 In vivo studies involving supplementation with hydroxytyrosol where high throughput proteomic analyses were performed
Model Dose & time Aim of study Ref.
Male C57BL/6 mice ∼45 mg HT per kg bw per
day. 8 weeks
Impact of long-term HT supplementation on the proteome in metabolically active
tissues (adipose tissue and liver)
42
Female Wistar rats 5 mg kg−1 day−1 21 days Proteomic analyses in cardiovascular tissues (aorta and heart) 22
Male Rowett Hooded
Lister rats
10 mg kg−1 diet. 12 weeks Effects in the liver through proteomics and network analysis 43
HT: Hydroxytyrosol; ACTN4: alpha-actinin-4; RPL8: 60S ribosomal protein L8; ALDH2: mitochondrial aldehyde dehydrogenase.
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the liver samples from the HT-supplemented animal models
and controls (Studies 1–4). Overall, we did not find significant
differences in any of the proteins analyzed in the livers of the
HT- (or their secoiridoids precursors) supplemented animals
compared with those of the controls (Fig. 4). In the liver
samples from Study 1, the HT-supplemented groups showed a
slight, statistically non-significant, decrease in VIM and
increase in HSPD1, compared with those of the controls
(Fig. 4A). In samples from Study 2, involving an acute inges-
tion of HT, a decrease in the expression was seen for PRDX1
and CAR3, and an increase in FASN, although statistical sig-
nificance was not reached (Fig. 4B). As for Study 3, in HT-sup-
plemented ApoE KO mice, non-significant decreases in the
expression of ACTN4 and an increase in VIM were observed
(Fig. 4C). Finally, a non-significant decrease in FASN was
observed in the liver of female Wistar rats (Study 4) (Fig. 4D).
CAR3 was not analyzed in Study 4 samples as the anti-mouse
antibody used had no cross-reactivity to rats.
3.5 Post-transcriptional regulation by miRNAs
Post-transcriptional regulation is commonplace in biological
systems and miRNAs bind complementarily to the 3′UTR
sequence mediating negative post-transcriptional regulation,27
in turn impacting the proteome.28 Thus, we next assessed the
modulation of miRNA levels and explored the potential impact
it could have on the proteome. The liver samples from Study 1
were subjected to small RNA sequencing and miRNAs were
analyzed (Fig. 5). From the 247 miRNAs detected in the mouse
liver samples (ESI Table S4†), only 4 were found to be differen-
tially expressed in the HT supplemented group after FDR
adjustment (Fig. 5A). From these, miR-802-5p, miR-30a-5p and
miR-146b-5p were up-regulated, whereas miR-423-3p was
down-regulated. Because one gene can be regulated by
different miRNAs, we also searched for validated targets likely
to be modulated by more than one miRNA responding to HT
treatment (Fig. 5B). Gene Interaction (GI) analysis was per-
formed (see Materials and methods for details) generating a
unique list of 279 genes potentially modulated by at least two
miRNAs. The genes modulated by the four miRNAs included
Ccdc117, Ntrk2, Mrpl17, Timm22, Zfp945, Ubxn7, Tmem71,
Slc30a7, Gucy1a2, 4931406C07Rik, Zdhhc21, and Dclk1
(Fig. 5B). In particular, Gucy1a2 is involved in an endothelin
signaling pathway, Zdhhc21 in metabolic processes (palmitoyl-
transferase), and Timm22/Ntrk2 in cellular component organiz-
ation. Gene ontology analysis of modulated miRNAs targets
(by more than one miRNA) suggested their involvement in the
regulation of major pathways, including the Wnt signaling
pathway (P00057), the CCKR signaling map (P06959) or the
inflammation mediated by the chemokine and cytokine signal-
ing pathway (P00031), among others (Fig. 5C). Finally, none of
the genes matched the ones obtained after the analysis of the
transcriptomic or proteomic data sets, suggesting that their
levels are not directly controlled by these specific miRNAs.
4 Discussion
Many nutritional intervention studies29,30 demonstrated that
food and its bioactive components affect the expression of
genes, which can impact disease prevention.31–34 High
Fig. 3 Venn diagram showing the common differentially expressed proteins identified by means of bioinformatic analysis. Proteomic data available
in the scientific literature from in vivo dietary supplementation with hydroxytyrosol.
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throughput transcriptome and proteome analysis can be very
useful in the discovery of new biomarkers and pathways impli-
cated in metabolic diseases.35 Moreover, high throughput ana-
lyses aid in assessing the physiological effect that bioactive
compounds exert on a wide variety of diseases such as
diabetes,36,37 obesity,38 and cancer.39,40 Hence, these tech-
niques are useful to explore the mechanisms of action of nutri-
ents and phytochemicals. Omics technologies are widely
adopted to concomitantly study the expression of thousands of
genes and proteins, generating a vast amount of data that
accumulates over time and is generally available in public
repositories. These data sets could potentially be exploited to
Fig. 4 Validation of common proteins predicted to be modulated by HT supplementation. A set of proteins were chosen after bioinformatic analysis
of proteomic data and validated in the liver samples of different intervention studies. Protein expression was analyzed by western blotting. (A) Male
young C57BL/6 mice (n = 7 per group) fed with a control or HT diet (45 mg HT per kg bw per day), for 8 weeks (Study 1). (B) Male young C57BL/6
mice administered (gavage) with an acute dose of 15 mg of HT dissolved in water and sacrificed 4 h after ingestion (n = 9) (Study 2). (C) Male young
homozygous apoE KO mice (n = 7 per group) fed with an aqueous solution of 10 mg HT per kg per day (n = 7), for 10 weeks (Study 3). (D) Female
Wistar rats (300–350 g, n = 4 per group) fed with a standard diet (SD) or SD supplemented with 5 mg HT per kg per day, for 21 days (Study 4). HT,
hydroxytyrosol.
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establish functional connections among compounds triggering
similar responses at the molecular level by using compu-
tational approaches involving machine learning tools such as
hierarchical clustering.41 For example, we can predict the
pharmacological properties of many molecules across different
biological systems and conditions solely based on their tran-
scriptional profiles.41 Yet, there are few applications of such
approaches in the emerging field of nutrigenomics, which
investigates the effects of food and nutrients on gene
expression.12 Here, we analyzed the available transcriptomic
and proteomic data to (1) identify differentially expressed
genes and proteins prevailing among studies addressing
Fig. 5 Liver miRNA analysis. (A) Scatter plot of the RNA-seq data of liver miRNAs from mice supplemented with HT, for 8 weeks. (B) Genetic inter-
action analysis between miRNAs and their likely miRNA targets. Target point sizes are directly correlated with the number of interactions within the
set of miRNAs. (C) Functional enrichment analysis of differentially expressed miRNA targets. HT, hydroxytyrosol.
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hydroxytyrosol supplementation in vivo and (2) validate the
identified differentially expressed genes and proteins as robust
targets of HT.
We first searched for in vivo experiments involving dietary
supplementation with HT where high throughput gene and
protein expression data were generated. Then, we identified a
signature of dozens of genes shared among the selected
studies which could be related to the biological effects associ-
ated with HT consumption. Although several genes exhibited
different expressions in at least two tissues, only four tran-
scripts were significantly modulated in the four tissues we ana-
lyzed, i.e. brain, adipose tissue, liver, and intestine. This
finding seemed to be particularly relevant, considering that
the data were obtained from two independent laboratories25,26
and microarrays platforms. Regarding differentially expressed
proteins, very few candidates (less than five) were identified as
commonly modulated in at least two different tissues
(heart, aortic, hepatic, and adipose tissues) and none was
common to all tissues. Proteomic data were generated from
three different laboratories.22,42,43 In silico analysis allowed us
to identify 18 genes and a reduced number of proteins, which
were subsequently tested for validation in rodent liver
samples. Knowing that the liver is crucial for lipid metabolism
and that samples were available from all studies, our hypoth-
esis was that consistent modulation of specific targets of HT
could be found in this tissue in animals supplemented with
HT.
The transcriptomics studies included in this work were per-
formed in five different tissues: breast, adipose tissue, intes-
tine, liver, and brain. Among the four commonly differentially
regulated genes selected for validation, Efr3a was down-regu-
lated in all tissues, except for the intestine. Plscr1 was downre-
gulated in all tissues, whereas Kctd2 was only downregulated
in the intestine and liver and Slc37a4 was upregulated in the
brain and adipose tissue. Validation of these four genes in the
liver samples from the selected studies (Studies 1–4) con-
firmed the upregulation of Slc37a4 in Studies 2 and 3. The
other genes did not change significantly, suggesting a large
inter-study variability. None of the 14 additionally selected
genes for validation (Fig. 1) changed in all four studies. While
some genes only changed in one study (Anks6, Plscr2, Lipe,
Snx16, Ppp1cb, Top1 and Tip2), others changed in two studies
(Sort1, Slc37a4, Rora and Fgf21). According to our results,
Study 4 showed the most reduced changes in gene expression,
but we do not know whether this is related to the fact that this
study was performed in rats rather than in mice. Moreover, in
contrast with the other three mice studies receiving HT, in this
study rats received secoiridoids.22 Secoiridoids are the major
precursors of HT, after their in vivo digestion.2 Regarding the
function of these genes, Sort1 influences plasma lipid concen-
tration.44 Slc37a4 is a glucose-6-phosphate translocase (G6PT),
which transports G6P from the cytoplasm into the endoplas-
mic reticulum (ER) lumen, and is involved in glucose metab-
olism.45 Rora is a nuclear receptor involved in multiple biologi-
cal processes, including lipid metabolism.46 Fgf21 is a meta-
bolic gene that influences plasma glucose and triglyceride
levels,47 and is a critical regulator of liver lipid homeostasis.48
Moreover, FGF21 is induced directly by PPARalpha in the liver
in response to fasting49 and its induction is required for the
normal activation of hepatic lipid oxidation and triglyceride
clearance.48 As such, induced expression of Fgf21 by HT
feeding could be beneficial against metabolic diseases.
Because Fgf21 and Rora are important contributors to meta-
bolic diseases, we further validated their response to HT sup-
plementation in a different cohort.20 Interestingly, C57Bl6J
mice receiving a single ingestion of HT dramatically increased
their hepatic expression of Fgf21 at 1, 2, and 4 h post-inges-
tion. This effect was also observed for Rora, but to a lower
degree 4 h post-ingestion (Fig. 6). In this sense, our bioinfor-
matic approach and further validation uncovered novel poss-
ible molecular targets of the beneficial effects of HT consump-
tion. A previous study performed in a different mouse model
showed that the repression of Fgf21 caused by a high fat diet
was reverted by HT supplementation.50 These and our current
data suggest Fgf21 to be a bona fide candidate target of HT.
Whether this effect occurs in humans is unknown and
deserves further investigation.
In the study by Tomé-Carneiro et al., 2017 where samples
deriving from Study 1 were used, a decrease in the expression
of FASN and PRDX1 was recorded, by both high throughput
proteomics and WB, in mice supplemented with HT for eight
weeks (Tomé-Carneiro et al., 2017).42 However, WB revealed
only non-significant changes for these proteins in the liver
samples tested for validation. WB analysis also revealed non-
significant changes for CAR3 in the studies used for validation,
despite it being reported as upregulated by high throughput
proteomics in Study 1.
According to high throughput proteomics, VIM was signifi-
cantly changed in the adipose tissue samples from Study 1
and the aortic tissue from Study 4. Here, however, WB analysis
Fig. 6 Hydroxytyrosol target liver mRNA expression of Fgf21 and Rora.
Effects of hydroxytyrosol on FGF21 (A) and RORA and (B) relative gene
expression in liver samples of C57Bl6J mice at different time points (1, 2
and 4 hours). Data shown as mean ± SEM. * p < 0.05 compared to the
control group; ** p < 0.0001 compared to the control group. (n = 9 per
group).
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showed non-significant changes for these proteins in the liver
samples used for validation. The statistically significant
changes observed for ACTN4 proteins in liver (Study 1), aortic,
and heart tissues (Study 4), by WB, were not confirmed in the
liver samples used for validation. Likewise, the statistically sig-
nificant changes observed for HSPD1 in adipose (Study 1),
hepatic (Study 3) and aortic (Study 4) tissues were not con-
firmed, by WB, in the liver samples used for validation.
Overall, none of the proteins selected for validation showed
consistent differential expression across the liver samples
tested here.
It is important to note that the transcriptional data analysis
was performed independently of the protein data levels and
that correlations between transcripts and proteins were not
intended during the validation process. Also, it is relevant to
mention that the list of common genes or proteins to be vali-
dated were common to at least two different studies, regardless
of whether the tissues subjected to high throughput analysis
matched or not. Indeed, in most cases, tissues from where
transcript (intestine, liver, adipose, brain or breast tumor) and
protein (liver, heart, aortic, or adipose) levels were selected did
not match. Thus, the lack of consistent validation of potential
targets of HT in response to dietary supplementation should
be seen with caution.
Other aspects of the complex regulatory variation from RNA
to protein may account for the lack of common tissue features
in response to HT supplementation. For instance, studies in
model organisms and humans have shown that variations in
mRNA and protein expression levels are often
uncorrelated.51,52 Few transcripts are exclusive to a particular
tissue and varies more across tissues than individuals,53 while
genetic variation can also influence the heterogenicity of the
protein expression in a diverse set of human tissues.52,54
Moreover, differences may also arise from alterations in post-
translational regulation. Regulation by ncRNAs, particularly
miRNAs, is among the plethora of posttranslational control-
ling pathways.
Although in the past few years increasing evidence has
suggested that food bioactive compounds can modulate the
expression of miRNAs in vitro,55 in animal models,56 and in
humans,57 very few studies have specifically focused on the
action of HT. For example, specific miRNAs, miR-958 and
miR-146a,59 were evaluated in vitro, whereas only one study
evaluated the whole miRNome in the mouse small intestine.20
Among the liver modulated miRNAs in response to HT sup-
plementation, miR-802-5p has been previously described as
being obesity-inducing and as being involved in glucose
metabolism impairment and in angiotensin signaling
regulation.60,61 As for miR-423-3p, its levels have been posi-
tively associated with cell growth in liver, colon or other types
of cancers.62,63 Induction of miR-30a-5p has been previously
described to ameliorate liver fibrosis64 or to suppress breast
tumor growth and metastasis.64,65 miR-146b has been shown
to attenuate non-alcoholic steatohepatitis,66 although its
down-regulation has been shown to promote cancer growth
and metastasis.67
Sustained intake of HT at dietary doses by mice resulted in
altered miRNA expression in the intestine (assessed in Study 1)
and the liver (assessed here). Of note, HT supplementation
resulted only in a consistent (p < 0.05) regulation of miR-802-
5p in both tissues (ESI Fig. S1†). The reduced number of
common modulated miRNAs found could be explained by
different aspects of miRNA biogenesis, function, and technical
analysis. For example, some miRNAs are tissue-specific.68 Also,
though the processing pattern of miRNAs in tissues and cell
lines may differ, it has been reported that, especially in cell
lines, several transcribed miRNAs are not processed to mature
miRNA.69 While miRNAs might play a role in the biological
action of HT, the very reduced number of HT studies evaluat-
ing miRNAs precludes any conclusion regarding their regulat-
ory potential at this point. However, the consistent induction
of miR-802-5p in two different tissues, in response to dietary
HT supplementation, seems to support a miRNA modulating
action of small natural molecules, which could be exploited as
a potential therapeutic alternative or adjuvant to the current
pharmacological arsenal targeting endogenous miRNAs.
5 Conclusions
High throughput transcriptomics and proteomics are powerful
tools that greatly contribute to the knowledge of how nutrition
affects the expression of a wide number of genes and proteins.
Although in vivo studies where these techniques are employed
to investigate the molecular effects of hydroxytyrosol are
increasing in number, they are still scarce. Therefore, we
believe that there is a growing need to integrate the accumulat-
ing data in order to identify the consistent targets of this bio-
active compound. Most of the genes and proteins identified
and tested here as potential HT targets showed inconsistent
modulation by HT. These results are, at least in part, due to
the limited number of in vivo studies available, with hetero-
geneous HT doses and supplementation times, where different
tissues were used for transcriptomic/proteomic analysis.
However, our transcriptomic analysis uncovered two novel
potential HT target candidates, i.e. Fgf21 and Rora. While we
certainly do not want to depreciate the important role of omics
and their related database, we feel that more attention should
be paid to the current pitfalls of this approach to nutritional
research. Over-emphasis should be avoided and more HT-sup-
plementation studies employing high throughput transcrip-
tomics and proteomics tools are needed for potential HT
targets to be identified and validated.
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